Target intelligence / Profile preview

Mitochondrial electron transport chain ubiquinone-binding sites (ETC Q-sites)

Target
ETC Q-sites
Molecular classification
Enzyme, Other
01

Overview

The mitochondrial electron transport chain (ETC) ubiquinone-binding sites (also known as Q-sites) are critical functional domains located within the multi-subunit respiratory complexes (Complex I, Complex II, and Complex III) embedded in the inner mitochondrial membrane. These sites facilitate the reversible reduction of ubiquinone (coenzyme Q) to ubiquinol, a key lipid-soluble electron carrier that shuttles electrons between the complexes to establish the proton gradient necessary for ATP synthesis. Because of their central role in cellular bioenergetics and redox homeostasis, these binding pockets are highly attractive therapeutic targets. Inhibiting these sites disrupts electron flow, leading to a dramatic decrease in ATP production and a compensatory shift toward glycolysis. Furthermore, blockade of ubiquinone-binding sites often triggers electron leakage and the subsequent generation of reactive oxygen species (ROS), which can selectively induce apoptosis in cancer cells (as seen with mitocans like alpha-tocopheryl succinate). However, targeting these sites carries significant safety risks, including systemic mitochondrial toxicity, lactic acidosis, and neurodegeneration, as exemplified by the neurotoxic effects of the canonical Complex I inhibitor rotenone.

Other names
Mitochondrial respiratory chain ubiquinone-binding sitesMitochondrial ETC ubiquinone-binding sitesMitochondrial Q-sitesMitochondrial quinone-binding sitesCoenzyme Q-binding sitesUbiquinone-binding pocketsMitochondrial respiratory chain quinone-binding sites
02

Biological functions

Cellular respirationOxidative phosphorylationElectron transportProton translocationATP synthesisReactive oxygen species generationApoptosisOther
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic diseaseInfectionOther
04

Safety considerations

Mitochondrial toxicityLactic acidosisNeurotoxicityCardiotoxicitySystemic metabolic crisis due to ATP depletionIncreased oxidative stress and cellular damage
05

Interacting drugs

9 more in the full profile.

06

Biomarkers

Reactive oxygen species (ROS) levelsMitochondrial membrane potential (ΔΨm)Oxygen consumption rate (OCR)ATP levelsLactate levelsSuccinate levelsNADH/NAD+ ratio

Beyond the preview

Go deeper on Mitochondrial electron transport chain ubiquinone-binding sites (ETC Q-sites).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain ubiquinone-binding sites (ETC Q-sites).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call